Literature DB >> 17044805

Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use.

Desiderio Passàli1, Lorenzo Salerni, Giulio Cesare Passàli, Francesco Maria Passàli, Luisa Bellussi.   

Abstract

Nasal decongestants are the most powerful drugs in the reduction of nasal obstruction. Despite their large use, local and systemic adverse reactions are frequent. The authors focus on the pharmacology of these kinds of drugs in light of the most recent knowledge on nasal pathophysiology. The ultrastructural anatomy of nasal mucosa explains the complexity of the possible interactions between the sympathomimetics and imidazoles derivates, and the submucosal layer. Nasal obstruction is one of the most frequent clinical problems that otorhinolaryngologists encounter daily, both in adults and children. All possible predisposing conditions to nasal obstruction are documented along with the better ways to diagnose them through nasal functionality tests. Active anterior rhinomanometry, acoustic rhinometry and the determination of mucociliary transport time represent, together with nasal endoscopy, the gold standard for an accurate diagnosis and the follow-up of the patient to cure. An updated review of the most significant works in this field and the best treatment protocol to avoid adverse effects, such as rhinitis medicamentosa, are reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044805     DOI: 10.1517/14740338.5.6.783

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  7 in total

Review 1.  Rhinitis medicamentosa: what an otolaryngologist needs to know.

Authors:  Jayesh Doshi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-19       Impact factor: 2.503

2.  Differences in the Intended Meaning of Congestion Between Patients and Clinicians.

Authors:  Edward D McCoul; Alaa E Mohammed; Peter M Debbaneh; Maria Carratola; Amit S Patel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

Review 3.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

Review 4.  Different Methods and Formulations of Drugs and Vaccines for Nasal Administration.

Authors:  Junhu Tai; Munsoo Han; Dabin Lee; Il-Ho Park; Sang Hag Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

5.  Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.

Authors:  Achim G Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

6.  Treatment of acute rhinitis with a nasal spray containing tramazoline and essential oils: a multicenter, uncontrolled, observational trial.

Authors:  Gábor Katona; Mónika Sultész; Zsolt Farkas; Andrea Gyimesi; Andor Hirschberg; János Huszka; Ferenc Radvánszky; Ákos Simon; Gabriella Fülöp; Júlia Láng; Mária Ablonczy; Günther Nirnberger; Claudia Holm
Journal:  Clin Transl Allergy       Date:  2015-11-04       Impact factor: 5.871

Review 7.  HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature.

Authors:  Luisa Maria Bellussi; Serena Cocca; Giulio Cesare Passali; Desideri Passali
Journal:  Int Arch Otorhinolaryngol       Date:  2017-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.